Treating Patients with Multiple Cardiac Conditions
Cardiovascular disease is the leading cause of death in the United States and worldwide. Clinical Practice Guidelines (CPGs) have been put into place to optimize care for patients with cardiovascular conditions. Cardiac guidelines contain specific considerations focused on the prevention, diagnosis, and management of treating patients with multiple cardiac conditions.
The highest percentage of patients with multiple cardiac conditions is among the older adult population. Therefore, CPGs need to address the complex implications of comorbidity for the care of cardiovascular patients. It is often necessary to deliberate between which condition requires the most immediate treatment and intervention, while also taking into consideration the other medical factors that are affecting patients with multiple cardiac conditions. Cardiac guidelines are continuing to be developing to explicitly focus on the need for chronic conditions to be addressed, with the specific focus on those with multiple chronic conditions. Effective management of people with multiple cardiac conditions is a priority in providing optimal care.
Cardiac Conditions
- AHRQ 2018 Screening for Cardiovascular Disease Risk with ECG Review by UPSTF
- 2018 Antithrombic Therapy for Atrial Fibrillation Chest Guideline Expert Panel Report
- Hypertension for People over 60
- Position Statement for Diabetes and Hypertension
- 2017 ACC AHA HFSA Guideline for the Management of Heart Failure
- 2017 American College of Cardiology and American Heart Association Hypertension Guideline
- AHRQ 2017 Omega-3 Fatty Acids and Cardiovascular Disease Current State of the Evidence
- US Preventitive Task Force 2016 Aspirin Usein Prevention of Cardiovascular Disease and Colorectal Cancer
- 2016 Use of Omega-3s and Cardiac Disease
- 2016 Transitions in Care Heart Failure
- Patients with Cardiovascular Disease and Concomitant Conditions
- CV Medication Errors
- PPIS and-Antiplatlet-RX
- AFIB Research Summit
- Cerebral Venous Embolism
- CV Rehabilitation
- HTN Elderly
- Reduction in CV Disease and Stroke
- The Management of Atrial Fibrillation - National Clinical Guideline Centre. London UK: National Institute for Health and Care Excellence (NICE)
- Heart Failure Systolic Dysfunction - University of Michigan Health System
- Use of Dietary Supplements in CV Disease
- Lipid Modification Cardiovascular Risk - National Clinical Guideline Centre. London UK: National Institute for Health and Care Excellence (NICE)
- Venous Thromboembolism Guideline University of Michigan
- JNC8 Guideline on Adult Hypertension
- Summary of Evidence Based Guideline Update
- Antithrombotic Therapy
- Unstable Angina
- Acute Heart Failure Diagnosis and Management - National Clinical Guideline Centre. London UK: National Institute for Health and Care Excellence (NICE)
- Evidence Based Guideline for High Blood Pressure in Adults - James, Carter, Dennison-Himmelfaarb, Lackland, LeFevre, MacKenzie, Ogedegbe, Smith, Svetkey, Taler, Townsend, Wright, Narva & Ortuiz, 8th National Committee (JNC-8)
- Essential Hypertension Guideline University of Michigan
- Mechanical Support in CHF Patients
- Cardiac Rythm Abnormalities
- Sodium, Blood Pressure and CV Disease
- Decision Making in CHF
- Triglycerides and CV Disease
- Lloyd-Jonesb Braun, Ndumele, Smith, Sperling, Virani, Blumenthal Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular